2022 Annual Meeting | IS3 - Invited Science: Alzheimer's Disease
Program Materials Program Evaluations
| 01:00 PM - 01:20 PM PDT | Speaker |
PET Imaging Biomarkers: What is the Outlook for Their Role in Research, Trials, and Practice?
Susan Landau, PhD |
| 01:00 PM - 01:00 PM PDT | Speaker |
Walk-in Slides
Charles C. Windon, MD |
| 01:20 PM - 01:40 PM PDT | Speaker |
IDEAS and New IDEAS: Amyloid PET in Diverse Populations
Charles C. Windon, MD |
| 01:40 PM - 02:00 PM PDT | Speaker |
Future Use and Implementation of AD Blood Biomarkers From a Clinical and Epidemiological Perspective
Michelle M. Mielke, PhD |
| 02:00 PM - 02:20 PM PDT | Speaker |
Plasma Biomarkers of Neurodegeneration and Neuroinflammation in Hospitalized COVID-19 Patients with and without New Neurological Symptoms
Thomas M. Wisniewski, MD |
| 02:20 PM - 02:40 PM PDT | Speaker |
Precision Medicine and Biomarkers in Nutrition Science for Dementia Prevention
Hussein Yassine, MD |
| 02:40 PM - 03:00 PM PDT | Speaker |
Diagnostic Criteria for Psychosis in Neurodegeneration
Corinne Fischer, MD |
| Susan Landau, PhD | Dr. Landau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KeifeRx. Dr. Landau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai, Inc. The institution of Dr. Landau has received research support from NIH. |
| Charles C. Windon, MD | Dr. Windon has received personal compensation in the range of $0-$499 for serving as a Consultant for LCN Consulting. Dr. Windon has received research support from Alzheimer's Association. Dr. Windon has received personal compensation in the range of $0-$499 for serving as a Educational Material Collaborator with American Academy of Neurology. |
| Michelle M. Mielke, PhD | Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunbird Bio. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Mielke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Mielke has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. |
| Thomas M. Wisniewski, MD | Dr. Wisniewski has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Aging Neuroscience. The institution of Dr. Wisniewski has received research support from the National Institute of Aging. Dr. Wisniewski has received intellectual property interests from a discovery or technology relating to health care. |
| Liana Apostolova, MD, FAAN | Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. An immediate family member of Dr. Apostolova has stock in Cassava Neurosciences. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. |
| Hussein Yassine, MD | Hussein Yassine, MD has nothing to disclose. |
| Ronald C. Petersen, MD, PhD, FAAN | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities. |
| Corinne Fischer, MD | The institution of Dr. Fischer has received research support from Vielight Inc. The institution of Dr. Fischer has received research support from Hoffman La Roche. |